30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

James Clemmer

Insider profile

Currently holds positions in Lantheus Holdings Inc and AngioDynamics Inc

Performance

Overall performance
3.6

Performance over holding periods
3.6
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 64% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Lantheus Holdings Inc July 9, 2015 -
President, Chief Executive Officer, Director AngioDynamics Inc April 4, 2016 -

James Clemmer's trades of AngioDynamics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-10-09 2025-10-09 B Purchase
85,365 +12.2%
93.63
US$48,238
85,365 +12.2% 93.63 US$48,238
2024-10-08 2024-10-07 B Purchase
69,034 +12.1%
204.93
US$1,267,593
69,034 +12.1% 204.93 US$1,267,593
2024-04-08 2024-04-08 B Purchase
50,997 +4.5%
159.00
US$625,056
50,997 +4.5% 159.00 US$625,056
2022-10-11 2022-10-10 B Purchase
10,000 +2.3%
15.00
US$150,000
10,000 +2.3% 15.00 US$150,000
2022-01-12 2022-01-11 B Purchase
10,000 +2.6%
22.84
US$228,400
10,000 +2.6% 22.84 US$228,400
2020-08-03 2020-07-31 B Purchase
40,000 +13.2%
8.26
US$330,400
40,000 +13.2% 8.26 US$330,400
2019-10-28 2019-10-25 B Purchase
15,000 +6.1%
14.19
US$212,850
15,000 +6.1% 14.19 US$212,850